AnaptysBio, Inc. (ANAB) Earnings
|
Expand Research on ANAB
| Next EPS Date | 8/10/26 | EPS Growth Rate | +73.9% |
|---|---|---|---|
| Average EPS % Beat Rate | +0.8% | Revenue Growth Rate | +10.2% |
| Average % Move 1-Wk after EPS | -1.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/10/26  |
Q226 | N/A | -$0.35 | N/A | N/A | $24.52M | N/A | N/A | N/A | ||
| 5/12/26 |
Q126 | -$1.84 | -$0.96 | -$0.88 | $25.56M | $23.04M | N/A |  | | Details | |
| 5/7/26 |
Q126 | N/A | -$0.96 | N/A | N/A | $23.04M | N/A | N/A | N/A | ||
| 3/3/26 |
Q425 | $1.58 | $0.87 | +$0.71 | $108.25M | $87.09M | N/A | | | Details | |
| 11/11/25 |
Q325 | N/A | -$1.40 | N/A | N/A | $15.85M | N/A | N/A | N/A | ||
| 8/7/25 |
Q225 | -$1.34 | -$1.52 | +$0.18 | $22.26M | $11.51M | N/A | | | Details | |
| 5/5/25 |
Q125 | -$1.28 | -$1.30 | +$0.02 | N/A | $13.7M | N/A | | | Details | |
| 2/27/25 | Q424 | -$0.72 | -$1.62 | +$0.90 | $43.11M | $8.44M | N/A | | | Details |
